EyeMarker Systems is Profiled in this Database

Updated At 12 Jul, 2021

Start Free 7 Day Trial Now
Partial description of this company
Ready-to-market medical device for assessing - via the eye - exposure to neurotoxins, cyanide, and low level radiation. Future products include assessment of mild TBI and other health conditions, including diabetic diseases of the eye.

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of EyeMarker Systems plus 5035 other startups.

Start Free 7 Day Trial Now

Learn More About EyeMarker Systems

Technology/product details

Potential acquirers

Revenue projections

Capital raised to date

Growth strategy

Market landscape

CEO presentation

More

Our Clients